| pubmed-article:21498392 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21498392 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:21498392 | lifeskim:mentions | umls-concept:C0683140 | lld:lifeskim |
| pubmed-article:21498392 | lifeskim:mentions | umls-concept:C0521447 | lld:lifeskim |
| pubmed-article:21498392 | lifeskim:mentions | umls-concept:C1517058 | lld:lifeskim |
| pubmed-article:21498392 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:21498392 | pubmed:dateCreated | 2011-5-17 | lld:pubmed |
| pubmed-article:21498392 | pubmed:abstractText | To determine the mechanisms by which tumors situated in extrahepatic sites can cause profound changes in hepatic drug clearance, contributing to altered drug response and chemotherapy resistance. | lld:pubmed |
| pubmed-article:21498392 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21498392 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21498392 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21498392 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21498392 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21498392 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21498392 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21498392 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21498392 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21498392 | pubmed:month | May | lld:pubmed |
| pubmed-article:21498392 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:21498392 | pubmed:author | pubmed-author:EvansRonald... | lld:pubmed |
| pubmed-article:21498392 | pubmed:author | pubmed-author:LiddleChristo... | lld:pubmed |
| pubmed-article:21498392 | pubmed:author | pubmed-author:RobertsonGrah... | lld:pubmed |
| pubmed-article:21498392 | pubmed:author | pubmed-author:ClarkeStephen... | lld:pubmed |
| pubmed-article:21498392 | pubmed:author | pubmed-author:SharmaRohiniR | lld:pubmed |
| pubmed-article:21498392 | pubmed:author | pubmed-author:KacevskaMarin... | lld:pubmed |
| pubmed-article:21498392 | pubmed:author | pubmed-author:DownesMichael... | lld:pubmed |
| pubmed-article:21498392 | pubmed:copyrightInfo | ©2011 AACR. | lld:pubmed |
| pubmed-article:21498392 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:21498392 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:21498392 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:21498392 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21498392 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21498392 | pubmed:pagination | 3170-80 | lld:pubmed |
| pubmed-article:21498392 | pubmed:meshHeading | pubmed-meshheading:21498392... | lld:pubmed |
| pubmed-article:21498392 | pubmed:meshHeading | pubmed-meshheading:21498392... | lld:pubmed |
| pubmed-article:21498392 | pubmed:meshHeading | pubmed-meshheading:21498392... | lld:pubmed |
| pubmed-article:21498392 | pubmed:meshHeading | pubmed-meshheading:21498392... | lld:pubmed |
| pubmed-article:21498392 | pubmed:meshHeading | pubmed-meshheading:21498392... | lld:pubmed |
| pubmed-article:21498392 | pubmed:meshHeading | pubmed-meshheading:21498392... | lld:pubmed |
| pubmed-article:21498392 | pubmed:meshHeading | pubmed-meshheading:21498392... | lld:pubmed |
| pubmed-article:21498392 | pubmed:meshHeading | pubmed-meshheading:21498392... | lld:pubmed |
| pubmed-article:21498392 | pubmed:meshHeading | pubmed-meshheading:21498392... | lld:pubmed |
| pubmed-article:21498392 | pubmed:meshHeading | pubmed-meshheading:21498392... | lld:pubmed |
| pubmed-article:21498392 | pubmed:meshHeading | pubmed-meshheading:21498392... | lld:pubmed |
| pubmed-article:21498392 | pubmed:meshHeading | pubmed-meshheading:21498392... | lld:pubmed |
| pubmed-article:21498392 | pubmed:meshHeading | pubmed-meshheading:21498392... | lld:pubmed |
| pubmed-article:21498392 | pubmed:meshHeading | pubmed-meshheading:21498392... | lld:pubmed |
| pubmed-article:21498392 | pubmed:meshHeading | pubmed-meshheading:21498392... | lld:pubmed |
| pubmed-article:21498392 | pubmed:meshHeading | pubmed-meshheading:21498392... | lld:pubmed |
| pubmed-article:21498392 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21498392 | pubmed:articleTitle | Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism. | lld:pubmed |
| pubmed-article:21498392 | pubmed:affiliation | Storr Liver Unit, Westmead Millennium Institute, University of Sydney, Westmead, New South Wales, Australia. | lld:pubmed |
| pubmed-article:21498392 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21498392 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:21498392 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
